Capital expenditure increased 110.6%
Capital expenditure changed +110.6% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
$3.8M→$7.9M6 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HAE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents decreased 23.7%
Cash & equivalents changed -23.7% from the comparable as-filed period.
$292.9M→$223.4M2 prior comparisons
Free-cash-flow proxy increased 225.6%
Free-cash-flow proxy changed +225.6% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
$13.6M→$44.4M6 prior comparisons
Operating cash flow increased 200.8%
Operating cash flow changed +200.8% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
$17.4M→$52.3M6 prior comparisons
Capex / revenue moved 116 bp higher
Capex / revenue changed +116 basis points from the comparable as-filed period.
1.17%→2.33%2 prior comparisons
Inventory decreased 14.9%
Inventory changed -14.9% from the comparable as-filed period.
$360.5M→$306.7M3 prior comparisons
Revenue increased 5.6%
Revenue changed +5.6% from the comparable as-filed period.
$321.4M→$339.4M3 prior comparisons
Selling, general & administrative increased 7.4%
Selling, general & administrative changed +7.4% from the comparable as-filed period.
$110.7M→$118.9M3 prior comparisons
Gross profit increased 5.5%
Gross profit changed +5.5% from the comparable as-filed period.
$192.2M→$202.8M3 prior comparisons
Operating income increased 6.7%
Operating income changed +6.7% from the comparable as-filed period.
$53.9M→$57.5M3 prior comparisons
Debt decreased 3.0%
Debt changed -3.0% from the comparable as-filed period.
$1.2B→$1.2B3 prior comparisons
Gross margin moved 6 bp lower
Gross margin changed -6 basis points from the comparable as-filed period.
59.82%→59.76%3 prior comparisons
Net income decreased 3.0%
Net income changed -3.0% from the comparable as-filed period.
$34.0M→$33.0M2 prior comparisons
Operating margin moved 17 bp higher
Operating margin changed +17 basis points from the comparable as-filed period.
16.76%→16.93%3 prior comparisons
Research & development decreased 0.4%
Research & development changed -0.4% from the comparable as-filed period.
$16.3M→$16.2M3 prior comparisons
Stock-based compensation decreased 0.0%
Stock-based compensation changed -0.0% from the comparable as-filed period.
$9.3M→$9.3M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.